The GENIE Consortium consists of 20 leading international cancer centers, dedicated to collaborative data sharing and precision oncology research.
Core Capabilities:
- Custom Research Solutions – Retrospective, prospective, and hybrid study designs.
- End-to-End Drug Development Support – From preclinical research to post-market surveillance.
- Regulatory-Grade RWD – Aligning with data used in late-stage clinical trials.